Stem Cell Therapy in Treating Epilepsy

Bao Luen Chang*, Kuo Hsuan Chang

*此作品的通信作者

研究成果: 期刊稿件文獻綜述同行評審

10 引文 斯高帕斯(Scopus)

摘要

Epilepsy is a common disabling chronic neurological disorder characterized by an enduring propensity for the generation of seizures that result from abnormal hypersynchronous firing of neurons in the brain. Over 20–30% of epilepsy patients fail to achieve seizure control or soon become resistant to currently available therapies. Prolonged seizures or uncontrolled chronic seizures would give rise to neuronal damage or death, astrocyte activation, reactive oxygen species production, and mitochondrial dysfunction. Stem cell therapy is potentially a promising novel therapeutic strategy for epilepsy. The regenerative properties of stem cell-based treatment provide an attractive approach for long-term seizure control, particularly in drug-resistant epilepsy. Embryonic stem cells (ESCs), mesenchymal stem cells (MSCs), neural stem cells (NSCs), induced pluripotent stem cells (iPSCs), and adipose-derived regenerative cells (ADRCs) are capable of differentiating into specialized cell types has been applied for epilepsy treatment in preclinical animal research and clinical trials. In this review, we focused on the advances in stem cell therapy for epilepsies. The goals of stem cell transplantation, its mechanisms underlying graft effects, the types of grafts, and their therapeutic effects were discussed. The cell and animal models used for investigating stem cell technology in epilepsy treatment were summarized.

原文英語
文章編號934507
期刊Frontiers in Neuroscience
16
DOIs
出版狀態已出版 - 27 06 2022
對外發佈

文獻附註

Publisher Copyright:
Copyright © 2022 Chang and Chang.

指紋

深入研究「Stem Cell Therapy in Treating Epilepsy」主題。共同形成了獨特的指紋。

引用此